Molecule to Market: Our top trends 2023; part 2

In this special end-of-year episode, you’ll go inside the outsourcing space of the global drug development sector with your host, Raman Sehgal, who reflects on the 50+ episodes and special guest interviews throughout 2023.

 

In the second part of our series on the top trends 2023, we dive deep into the dynamic and ever-evolving life sciences sector. From its various life cycles to the winds of change shaping the industry in 2024, there is a positive upturn on the horizon.

In part two of the top trends from 2023, Raman identified trends including:

• How the M&A market has suffered in a fractured CDMO space over the last 12 months
• The new breed of biotechs coming to the life sciences market and what they are doing differently to be slimmer and more capital-efficient
• The rise of artificial intelligence and the importance it will play in the digitization of the sector 
• Why adaptability and flexibility are causing a sizable impact on an uncertain financial market in the life sciences sector
• Why the term “Green Shoots” is back in the life sciences vocabulary 

Catch up on Part One! 

 

Subscribe, tell your industry colleagues, and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!

 

Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital, and content agency helping companies differentiate, get noticed and grow in life sciences.